Would you consider adjuvant radiation for a patient with recurrent pelvic node melanoma s/p immunotherapy and pelvic lymph node dissection with complete pathological response (only necrotic tissue; no viable melanoma)?
1 Answer
Mednet MemberInvited Expert
Radiation Oncology · Memorial Sloan Kettering Cancer Center
Answered on
At this point, no. These patients seem to have a low risk of recurrence if they experience pathologic complete response following neoadjuvant immunotherapy.
Join for free or sign in to see the full answer